Research Articles | Page 5 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients Nov 2020 Blood Advances myelodysplastic syndromes (MDS)
Paroxysmal nocturnal haemoglobinuria (PNH): novel therapies for an ancient disease Nov 2020 British Journal of Haematology paroxysmal nocturnal hemoglobinuria (PNH)
Myelodysplastic syndromes: 2021 update on diagnosis, risk stratification and management Nov 2020 American Journal of Hematology myelodysplastic syndromes (MDS)
Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience Nov 2020 Leukemia & Lymphoma myelodysplastic syndromes (MDS)
The Genomics of Myelodysplastic Syndromes: Origins of Disease Evolution, Biological Pathways, and Prognostic Implications Nov 2020 Cells myelodysplastic syndromes (MDS)
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes Nov 2020 Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation myelodysplastic syndromes (MDS)
Danicopan: an oral complement factor D inhibitor for paroxysmal nocturnal hemoglobinuria Oct 2020 Haematologica paroxysmal nocturnal hemoglobinuria (PNH)
Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion-Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study Oct 2020 Journal of clinical oncology: official journal of the American Society Clinical Oncology myelodysplastic syndromes (MDS)
One-year efficacy and safety of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria naïve to complement inhibitor therapy: open-label extension of a randomized study Oct 2020 Therapeutic Advances in Hematology paroxysmal nocturnal hemoglobinuria (PNH)
Silver lining: reduced relapse with chronic GVHD after transplant for MDS Oct 2020 Clinical Cancer Research: an official Journal of the American Association of Cancer Research graft versus host disease (GVHD), myelodysplastic syndromes (MDS)
Share with addtoany.com.